BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 16647996)

  • 1. Level of tau protein in children treated for acute lymphoblastic leukemia.
    Muszyńska-Rosłan K; Krawczuk-Rybak M; Protas PT; Hołownia A
    Pediatr Neurol; 2006 May; 34(5):367-71. PubMed ID: 16647996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Negative correlation between cerebrospinal fluid tau protein and cognitive functioning in children with acute lymphoblastic leukemia.
    Protas PT; Muszynska-Roslan K; Holownia A; Grabowska A; Wielgat P; Krawczuk-Rybak M; Braszko JJ
    Pediatr Blood Cancer; 2009 Jul; 53(1):105-8. PubMed ID: 19309718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal fluid oxidative stress during chemotherapy of acute lymphoblastic leukemia in children.
    Protas PT; Muszynska-Roslan K; Holownia A; Krawczuk-Rybak M; Braszko JJ
    Pediatr Hematol Oncol; 2010 May; 27(4):306-13. PubMed ID: 20426521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MCP-1 in the cerebrospinal fluid of children with acute lymphoblastic leukemia.
    Eisenkraft A; Keidan I; Bielorai B; Keller N; Toren A; Paret G
    Leuk Res; 2006 Oct; 30(10):1259-61. PubMed ID: 16516290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folate homeostasis in cerebrospinal fluid during therapy for acute lymphoblastic leukemia.
    Cole PD; Beckwith KA; Vijayanathan V; Roychowdhury S; Smith AK; Kamen BA
    Pediatr Neurol; 2009 Jan; 40(1):34-41. PubMed ID: 19068252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cytological findings of the cerebrospinal fluid at diagnosis of acute lymphocytic leukemia in children--effect of remission induction chemotherapy].
    Kinumaki H; Bessho F; Yokota S
    Rinsho Ketsueki; 1989 Oct; 30(10):1763-8. PubMed ID: 2593242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurotoxicity marker profiles in the CSF are not age-dependent but show variation in children treated for acute lymphoblastic leukemia.
    Van Gool SW; De Meyer G; Van de Voorde A; Vanmechelen E; Vanderstichele H
    Neurotoxicology; 2004 Mar; 25(3):471-80. PubMed ID: 15019310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal fluid total tau protein levels in patients with multiple sclerosis.
    Terzi M; Birinci A; Cetinkaya E; Onar MK
    Acta Neurol Scand; 2007 May; 115(5):325-30. PubMed ID: 17489943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal fluid cleaved-tau protein and 9-hydroxyoctadecadienoic acid concentrations in pediatric patients with hydrocephalus.
    Cengiz P; Zemlan F; Ellenbogen R; Hawkins D; Zimmerman JJ
    Pediatr Crit Care Med; 2008 Sep; 9(5):524-9. PubMed ID: 18679140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased total-Tau levels in cerebrospinal fluid of pediatric hydrocephalus and brain tumor patients.
    de Bont JM; Vanderstichele H; Reddingius RE; Pieters R; van Gool SW
    Eur J Paediatr Neurol; 2008 Jul; 12(4):334-41. PubMed ID: 17951083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurochemical markers of brain damage in cerebrospinal fluid during induction treatment of acute lymphoblastic leukemia in children.
    Osterlundh G; Kjellmer I; Lannering B; Rosengren L; Nilsson UA; Márky I
    Pediatr Blood Cancer; 2008 Apr; 50(4):793-8. PubMed ID: 17973312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapy and attentional dysfunction in survivors of childhood acute lymphoblastic leukemia: effect of treatment intensity.
    Buizer AI; de Sonneville LM; van den Heuvel-Eibrink MM; Veerman AJ
    Pediatr Blood Cancer; 2005 Sep; 45(3):281-90. PubMed ID: 15806539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between high vascular endothelial growth factor-A serum levels and treatment outcome in patients with standard-risk acute lymphoblastic leukemia: a report from Children's Oncology Group Study CCG-1962.
    Avramis IA; Panosyan EH; Dorey F; Holcenberg JS; Avramis VI;
    Clin Cancer Res; 2006 Dec; 12(23):6978-84. PubMed ID: 17145817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Acute lymphoblastic leukemia in children with initial leucocytosis above 50,000/mm3: summary of treatment results of Polish Pediatric Leukemia/Lymphoma Study Group].
    Skoczeń S; Balwierz W; Moryl-Bujakowska A; Pawińska K; Luszczyńska A; Balcerska A; Płoszyńska A; Chybicka A; Dobaczewski G; Juszczak K; Wachowiak J; Derwich K; Kowalczyk J; Wiśniewska-Slusarz H; Matysiak M; Krauze A; Pawelec K; Sońta-Jakimczyk D; Tomaszewska R; Wysocki M; Styczyńskii J; Swiatkiewicz V;
    Przegl Lek; 2006; 63(1):11-4. PubMed ID: 16892892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tau protein in the cerebrospinal fluid is a marker of brain injury after aortic surgery.
    Shiiya N; Kunihara T; Miyatake T; Matsuzaki K; Yasuda K
    Ann Thorac Surg; 2004 Jun; 77(6):2034-8. PubMed ID: 15172260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of cerebrospinal fluid beta-glucuronidase activity with plasma methotrexate concentrations in leukemic children receiving high-dose methotrexate.
    Vlacha V; Eliopoulou M; Haidas S; Beratis NG
    Pediatr Blood Cancer; 2004 Apr; 42(4):350-6. PubMed ID: 14966832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Accretion of bone mass in patients treated for childhood acute lymphoblastic leukemia].
    Muszyńska-Rosłan K; Konstantynowicz J; Krawczuk-Rybak M
    Pol Merkur Lekarski; 2007 Oct; 23(136):271-5. PubMed ID: 18293849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of the complete clearance of peripheral blasts after 7 days of prednisolone treatment in children with acute lymphoblastic leukemia: the Tokyo Children's Cancer Study Group Study L99-15.
    Manabe A; Ohara A; Hasegawa D; Koh K; Saito T; Kiyokawa N; Kikuchi A; Takahashi H; Ikuta K; Hayashi Y; Hanada R; Tsuchida M;
    Haematologica; 2008 Aug; 93(8):1155-60. PubMed ID: 18519521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrospinal fluid lactic dehydrogenase activity in children with acute lymphoblastic leukemia treated for cranial prophylaxis.
    Caglar MK; Hicsonmez G; Renda N
    Paediatr Indones; 1989; 29(5-6):112-5. PubMed ID: 2812823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tau protein, phosphorylated tau protein and beta-amyloid42 in the cerebrospinal fluid of multiple sclerosis patients.
    Valis M; Talab R; Stourac P; Andrys C; Masopust J
    Neuro Endocrinol Lett; 2008 Dec; 29(6):971-6. PubMed ID: 19112391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.